Clinical Trials Browser

Active not recruiting × Brain Neoplasms × Dasatinib × Clear all

NCT02389309 2026-03-09

Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors

Phase 1 Active not recruiting

Brain Neoplasms